10.0 Point of Care for HCV in Community Settings

Posted in: HCV

No Point of Care (PoC) tests for HCV are currently approved for use in Australia, however, a number of anti-HCV tests which show a similar sensitivity and specificity to commercial laboratory anti-HCV enzyme immunoassays have Food and Drug Administration (FDA) approval and CE marking. Such rapid assays may yet find a niche in HCV testing in Australia; they offer an opportunity for testing of people who may otherwise not seek help from traditional medical settings and can provide a result without the individual returning to the site at a later date. 

These tests are likely to be inappropriate for testing of low prevalence populations.

When a PoC test is approved for use in Australia, this section of the policy will be updated.

Some people in the community may access self-administered PoC test from overseas for their personal use. Due to the lack of TGA approval and the variability in test sensitivity and specificity, if  a person indicates they have received a positive or negative PoC test result, this then should be confirmed by standard HCV testing in a NATA accredited diagnostic laboratory.

Further information on Point of Care testing for HCV can be found here.

Quick links to resources on this page

Point of Care tests for HCV in community settings